Private Equity PE Fund Investments
PAG consortium acquires controlling stake in Optimus Drugs
A Private Equity consortium led by Pacific Alliance Group (PAG) and including CX Partners and Samara Capital, is to acquire a controlling stake in Hyderabad-based pharmaceutical firm Optimus Drugs at a value of over INR 2,000 crore.
Jayendra Shah acted as transaction advisor, N.A. Shah Advisory Services LLP acted as financial and tax advisors and Khaitan & Co. acted as legal advisors to the promoters in the transaction. For the PAG-led consortium, AZB & Partners acted as legal advisors and Citadel Management Consulting acted as financial advisor.
Optimus Drugs is a vertically integrated manufacturer of pharmaceutical products including advanced intermediates, active pharmaceutical ingredients (APIs) and finished drugs. The company exports more than 100 drug products to 40 countries.
Company website ↗ (opens in a new tab)
From the Venture Intelligence Private Company Financials Database: For Fy21, Optimus Drugs had reported an operational income of over INR 1,000-Cr. (Subscribers to the database can login to view the detailed financials.)